INT239668

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.10
First Reported 2008
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 2
Disease Relevance 0.67
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

endoplasmic reticulum (S100a10)
Anatomy Link Frequency
Langerhans cell 2
S100a10 (Rattus norvegicus)
Pain Link Frequency Relevance Heat
Paracetamol 28 5.00 Very Low Very Low Very Low
alcohol 20 5.00 Very Low Very Low Very Low
Inflammation 18 5.00 Very Low Very Low Very Low
Inflammatory response 10 5.00 Very Low Very Low Very Low
chemokine 4 5.00 Very Low Very Low Very Low
Bile 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Cancer 10 97.28 Very High Very High Very High
Injury 34 65.12 Quite High
Necrosis 216 62.56 Quite High
Death 10 58.64 Quite High
Apoptosis 38 50.00 Quite Low
Hepatotoxicity 34 50.00 Quite Low
INFLAMMATION 28 5.00 Very Low Very Low Very Low
Toxicity 10 5.00 Very Low Very Low Very Low
Overdose 2 5.00 Very Low Very Low Very Low
Fatty Liver 2 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Four gene-to-gene interactions (S100 Calpactin [S100a10] with annexin A2 [Anxa2], Lectin, galactose binding, soluble 3 [Lgals3] with Epidermal Langerhans cell protein [Lcp1], Tumor protein p53 [TP53] with Cathepsin H [Ctsh] and Mitogen activated protein kinase 1 [Mapk1] with Caspase 8 [Casp8]) with probabilities greater than 0.8 are consistent with the interactions in the biological pathway generated from curation of scientific literature (Figure 4).


S100 Calpactin Binding (binding) of in Langerhans cell associated with cancer
1) Confidence 0.10 Published 2008 Journal BMC Genomics Section Body Doc Link PMC2478688 Disease Relevance 0.34 Pain Relevance 0
Four gene-to-gene interactions (S100 Calpactin [S100a10] with annexin A2 [Anxa2], Lectin, galactose binding, soluble 3 [Lgals3] with Epidermal Langerhans cell protein [Lcp1], Tumor protein p53 [TP53] with Cathepsin H [Ctsh] and Mitogen activated protein kinase 1 [Mapk1] with Caspase 8 [Casp8]) with probabilities greater than 0.8 are consistent with the interactions in the biological pathway generated from curation of scientific literature (Figure 4).


S100 Calpactin Binding (interactions) of in Langerhans cell associated with cancer
2) Confidence 0.08 Published 2008 Journal BMC Genomics Section Body Doc Link PMC2478688 Disease Relevance 0.32 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox